Skip to main content
Clinical Trials/JPRN-UMIN000041670
JPRN-UMIN000041670Completed未知

Clinical trial on the absorption of triglyceride form of DHA by intake conditions (Pilot Study)-A randomized open label crossover study - Study about the difference of triglyceride form of DHA absorption by the effect of food intake.

FANCL Corporation0 sites30 target enrollmentStarted: September 3, 2020Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 65years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. Patient with dyslipidaemia. 2. Subjects with severe liver diseases, digestive organ diseases, kidney diseases and heart diseases. 3. Subjects who have history of surgical resection of the gastrointestinal tract (except for appendectomy). 4. Subjects who have various symptoms of indigestion (diarrhea, stomach feels upset etc.). 5. Subjects who are bleeding at present or danger of bleeding (serious injuries and operations, etc.) 6. Can't stop to take a supplement or medicine including DHA, EPA during the study period. 7. Difficulty in collecting blood. 8. Smoker 9. Subjects who are planned to participate in other clinical study. 10. Subjects who intend to become pregnant or lactating. 11. Subjects who are judged as unsuitable for the study by the investigator for other reason

Investigators

Similar Trials